The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Screening Market Research Report 2025
Synopsis
The global Diabetes Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Diabetes Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diabetes Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Diabetes Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Diabetes Screening include InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG, PTS Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diabetes Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Screening.
The Diabetes Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
InSphero AG
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc.
Ortho Clinical Diagnostics Inc.
F. Hoffmann-la Roche Ltd
Siemens AG
PTS Diagnostics
Segment by Type
Instrument
Test Suite
Reagents
Segment by Application
Hospital
Specialty Clinic
Diagnostic Center
Home Care
Academic Research Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Diabetes Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Diabetes Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diabetes Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Diabetes Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Diabetes Screening include InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG, PTS Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diabetes Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Screening.
The Diabetes Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
InSphero AG
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc.
Ortho Clinical Diagnostics Inc.
F. Hoffmann-la Roche Ltd
Siemens AG
PTS Diagnostics
Segment by Type
Instrument
Test Suite
Reagents
Segment by Application
Hospital
Specialty Clinic
Diagnostic Center
Home Care
Academic Research Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instrument
1.2.3 Test Suite
1.2.4 Reagents
1.3 Market by Application
1.3.1 Global Diabetes Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Diagnostic Center
1.3.5 Home Care
1.3.6 Academic Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Screening Market Perspective (2019-2030)
2.2 Global Diabetes Screening Growth Trends by Region
2.2.1 Global Diabetes Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Screening Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Screening Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Screening Market Dynamics
2.3.1 Diabetes Screening Industry Trends
2.3.2 Diabetes Screening Market Drivers
2.3.3 Diabetes Screening Market Challenges
2.3.4 Diabetes Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Screening Players by Revenue
3.1.1 Global Top Diabetes Screening Players by Revenue (2019-2024)
3.1.2 Global Diabetes Screening Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetes Screening Revenue
3.4 Global Diabetes Screening Market Concentration Ratio
3.4.1 Global Diabetes Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Screening Revenue in 2023
3.5 Global Key Players of Diabetes Screening Head office and Area Served
3.6 Global Key Players of Diabetes Screening, Product and Application
3.7 Global Key Players of Diabetes Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Screening Breakdown Data by Type
4.1 Global Diabetes Screening Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Screening Forecasted Market Size by Type (2025-2030)
5 Diabetes Screening Breakdown Data by Application
5.1 Global Diabetes Screening Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Screening Market Size (2019-2030)
6.2 North America Diabetes Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetes Screening Market Size by Country (2019-2024)
6.4 North America Diabetes Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Screening Market Size (2019-2030)
7.2 Europe Diabetes Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetes Screening Market Size by Country (2019-2024)
7.4 Europe Diabetes Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Screening Market Size (2019-2030)
8.2 Asia-Pacific Diabetes Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetes Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetes Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Screening Market Size (2019-2030)
9.2 Latin America Diabetes Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetes Screening Market Size by Country (2019-2024)
9.4 Latin America Diabetes Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Screening Market Size (2019-2030)
10.2 Middle East & Africa Diabetes Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetes Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetes Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 InSphero AG
11.1.1 InSphero AG Company Details
11.1.2 InSphero AG Business Overview
11.1.3 InSphero AG Diabetes Screening Introduction
11.1.4 InSphero AG Revenue in Diabetes Screening Business (2019-2024)
11.1.5 InSphero AG Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Diabetes Screening Introduction
11.2.4 Abbott Laboratories Revenue in Diabetes Screening Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 American Laboratory Products Company (ALPCO)
11.3.1 American Laboratory Products Company (ALPCO) Company Details
11.3.2 American Laboratory Products Company (ALPCO) Business Overview
11.3.3 American Laboratory Products Company (ALPCO) Diabetes Screening Introduction
11.3.4 American Laboratory Products Company (ALPCO) Revenue in Diabetes Screening Business (2019-2024)
11.3.5 American Laboratory Products Company (ALPCO) Recent Development
11.4 Beckmann Coulter Inc.
11.4.1 Beckmann Coulter Inc. Company Details
11.4.2 Beckmann Coulter Inc. Business Overview
11.4.3 Beckmann Coulter Inc. Diabetes Screening Introduction
11.4.4 Beckmann Coulter Inc. Revenue in Diabetes Screening Business (2019-2024)
11.4.5 Beckmann Coulter Inc. Recent Development
11.5 Bio-Rad Laboratories Inc.
11.5.1 Bio-Rad Laboratories Inc. Company Details
11.5.2 Bio-Rad Laboratories Inc. Business Overview
11.5.3 Bio-Rad Laboratories Inc. Diabetes Screening Introduction
11.5.4 Bio-Rad Laboratories Inc. Revenue in Diabetes Screening Business (2019-2024)
11.5.5 Bio-Rad Laboratories Inc. Recent Development
11.6 Ortho Clinical Diagnostics Inc.
11.6.1 Ortho Clinical Diagnostics Inc. Company Details
11.6.2 Ortho Clinical Diagnostics Inc. Business Overview
11.6.3 Ortho Clinical Diagnostics Inc. Diabetes Screening Introduction
11.6.4 Ortho Clinical Diagnostics Inc. Revenue in Diabetes Screening Business (2019-2024)
11.6.5 Ortho Clinical Diagnostics Inc. Recent Development
11.7 F. Hoffmann-la Roche Ltd
11.7.1 F. Hoffmann-la Roche Ltd Company Details
11.7.2 F. Hoffmann-la Roche Ltd Business Overview
11.7.3 F. Hoffmann-la Roche Ltd Diabetes Screening Introduction
11.7.4 F. Hoffmann-la Roche Ltd Revenue in Diabetes Screening Business (2019-2024)
11.7.5 F. Hoffmann-la Roche Ltd Recent Development
11.8 Siemens AG
11.8.1 Siemens AG Company Details
11.8.2 Siemens AG Business Overview
11.8.3 Siemens AG Diabetes Screening Introduction
11.8.4 Siemens AG Revenue in Diabetes Screening Business (2019-2024)
11.8.5 Siemens AG Recent Development
11.9 PTS Diagnostics
11.9.1 PTS Diagnostics Company Details
11.9.2 PTS Diagnostics Business Overview
11.9.3 PTS Diagnostics Diabetes Screening Introduction
11.9.4 PTS Diagnostics Revenue in Diabetes Screening Business (2019-2024)
11.9.5 PTS Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Diabetes Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Instrument
Table 3. Key Players of Test Suite
Table 4. Key Players of Reagents
Table 5. Global Diabetes Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Diabetes Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Diabetes Screening Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Diabetes Screening Market Share by Region (2019-2024)
Table 9. Global Diabetes Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Diabetes Screening Market Share by Region (2025-2030)
Table 11. Diabetes Screening Market Trends
Table 12. Diabetes Screening Market Drivers
Table 13. Diabetes Screening Market Challenges
Table 14. Diabetes Screening Market Restraints
Table 15. Global Diabetes Screening Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Diabetes Screening Market Share by Players (2019-2024)
Table 17. Global Top Diabetes Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Screening as of 2023)
Table 18. Ranking of Global Top Diabetes Screening Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Diabetes Screening Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Diabetes Screening, Headquarters and Area Served
Table 21. Global Key Players of Diabetes Screening, Product and Application
Table 22. Global Key Players of Diabetes Screening, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetes Screening Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Diabetes Screening Revenue Market Share by Type (2019-2024)
Table 26. Global Diabetes Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Diabetes Screening Revenue Market Share by Type (2025-2030)
Table 28. Global Diabetes Screening Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Diabetes Screening Revenue Market Share by Application (2019-2024)
Table 30. Global Diabetes Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Diabetes Screening Revenue Market Share by Application (2025-2030)
Table 32. North America Diabetes Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Diabetes Screening Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Diabetes Screening Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Diabetes Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Diabetes Screening Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Diabetes Screening Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Diabetes Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Diabetes Screening Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Diabetes Screening Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Diabetes Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Diabetes Screening Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Diabetes Screening Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Diabetes Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Diabetes Screening Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Diabetes Screening Market Size by Country (2025-2030) & (US$ Million)
Table 47. InSphero AG Company Details
Table 48. InSphero AG Business Overview
Table 49. InSphero AG Diabetes Screening Product
Table 50. InSphero AG Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 51. InSphero AG Recent Development
Table 52. Abbott Laboratories Company Details
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Diabetes Screening Product
Table 55. Abbott Laboratories Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. American Laboratory Products Company (ALPCO) Company Details
Table 58. American Laboratory Products Company (ALPCO) Business Overview
Table 59. American Laboratory Products Company (ALPCO) Diabetes Screening Product
Table 60. American Laboratory Products Company (ALPCO) Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 61. American Laboratory Products Company (ALPCO) Recent Development
Table 62. Beckmann Coulter Inc. Company Details
Table 63. Beckmann Coulter Inc. Business Overview
Table 64. Beckmann Coulter Inc. Diabetes Screening Product
Table 65. Beckmann Coulter Inc. Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 66. Beckmann Coulter Inc. Recent Development
Table 67. Bio-Rad Laboratories Inc. Company Details
Table 68. Bio-Rad Laboratories Inc. Business Overview
Table 69. Bio-Rad Laboratories Inc. Diabetes Screening Product
Table 70. Bio-Rad Laboratories Inc. Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 71. Bio-Rad Laboratories Inc. Recent Development
Table 72. Ortho Clinical Diagnostics Inc. Company Details
Table 73. Ortho Clinical Diagnostics Inc. Business Overview
Table 74. Ortho Clinical Diagnostics Inc. Diabetes Screening Product
Table 75. Ortho Clinical Diagnostics Inc. Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 76. Ortho Clinical Diagnostics Inc. Recent Development
Table 77. F. Hoffmann-la Roche Ltd Company Details
Table 78. F. Hoffmann-la Roche Ltd Business Overview
Table 79. F. Hoffmann-la Roche Ltd Diabetes Screening Product
Table 80. F. Hoffmann-la Roche Ltd Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 81. F. Hoffmann-la Roche Ltd Recent Development
Table 82. Siemens AG Company Details
Table 83. Siemens AG Business Overview
Table 84. Siemens AG Diabetes Screening Product
Table 85. Siemens AG Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 86. Siemens AG Recent Development
Table 87. PTS Diagnostics Company Details
Table 88. PTS Diagnostics Business Overview
Table 89. PTS Diagnostics Diabetes Screening Product
Table 90. PTS Diagnostics Revenue in Diabetes Screening Business (2019-2024) & (US$ Million)
Table 91. PTS Diagnostics Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Diabetes Screening Picture
Figure 2. Global Diabetes Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diabetes Screening Market Share by Type: 2023 VS 2030
Figure 4. Instrument Features
Figure 5. Test Suite Features
Figure 6. Reagents Features
Figure 7. Global Diabetes Screening Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Diabetes Screening Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Specialty Clinic Case Studies
Figure 11. Diagnostic Center Case Studies
Figure 12. Home Care Case Studies
Figure 13. Academic Research Institution Case Studies
Figure 14. Diabetes Screening Report Years Considered
Figure 15. Global Diabetes Screening Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Diabetes Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Diabetes Screening Market Share by Region: 2023 VS 2030
Figure 18. Global Diabetes Screening Market Share by Players in 2023
Figure 19. Global Top Diabetes Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Screening as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Diabetes Screening Revenue in 2023
Figure 21. North America Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Diabetes Screening Market Share by Country (2019-2030)
Figure 23. United States Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Diabetes Screening Market Share by Country (2019-2030)
Figure 27. Germany Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Diabetes Screening Market Share by Region (2019-2030)
Figure 35. China Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Diabetes Screening Market Share by Country (2019-2030)
Figure 43. Mexico Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Diabetes Screening Market Share by Country (2019-2030)
Figure 47. Turkey Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Diabetes Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. InSphero AG Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 51. Abbott Laboratories Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 52. American Laboratory Products Company (ALPCO) Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 53. Beckmann Coulter Inc. Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 54. Bio-Rad Laboratories Inc. Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 55. Ortho Clinical Diagnostics Inc. Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 56. F. Hoffmann-la Roche Ltd Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 57. Siemens AG Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 58. PTS Diagnostics Revenue Growth Rate in Diabetes Screening Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
